Pacific Biosciences of Ca...

NASDAQ: PACB · Real-Time Price · USD
1.30
0.07 (5.69%)
At close: Aug 15, 2025, 2:59 PM

Pacific Biosciences of California Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-41.93M -426.07M 2.37M -60.73M -173.32M -78.18M -82.02M -66.87M -69.83M -88.02M -84.38M -76.97M -71.39M -81.5M -69.33M 16.54M -41M -87.44M
Depreciation & Amortization
2.42M 372.78M 10.95M 16.1M 14.29M 12.01M 11.7M 5.46M 4.86M 4.52M 4.54M 4.32M 4.27M 4.19M 4.08M 2.71M 2.39M 2.4M
Stock-Based Compensation
11.89M 9.2M 16.03M 18.26M 17.22M 19.52M 16.58M 19.69M 17.89M 17.95M 17.95M 18.94M 19.02M 22.7M 18.94M 28.45M 15.8M 10.16M
Other Working Capital
-2.95M 5.8M -4.19M -16.08M 4.15M -26.63M -9.12M -2.55M -2.74M -24.07M 1.19M -10.65M -4.06M -20.87M 12.07M 8.53M 4.4M -2.4M
Other Non-Cash Items
2.11M 2.97M -68.16M -1.83M 93.88M -3.69M 4.58M -157K 830K 13.98M 9.67M 4.37M -5.28M -46K 2.26M 155K 152K 52.07M
Deferred Income Tax
n/a -546K -205K n/a n/a n/a -718K -10.71M -1.31M n/a n/a n/a n/a n/a 1.18M -93.5M 1.22M 565K
Change in Working Capital
-3.87M -2.39M 8.37M -17.27M -6.33M -25.35M -7.74M -12.6M 4.51M -43.13M -8.35M -13.71M -7.54M -24.38M 11.16M 4.99M 5.72M -869K
Operating Cash Flow
-29.38M -44.06M -30.65M -45.46M -54.26M -75.68M -57.61M -65.18M -41.74M -94.69M -60.57M -63.05M -60.56M -79.03M -31.71M -40.66M -15.71M -23.1M
Capital Expenditures
4.45M -6.39M -1.62M 787K -1.48M -3.88M -2.02M -830K -2.27M -3.72M -5.08M -4.19M -4.02M -3.64M -2.84M -1.12M -1.57M -401K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -102K 96.32M 68.83M 179K -58.1M n/a n/a n/a -319.79M n/a n/a
Purchase of Investments
-56.17M -61.82M -80.47M -114.6M -111.66M -191.91M -202.82M -76.87M -243.59M -233.29M -134.89M -66.81M -164.72M -76.37M -130.63M -222.02M -570.97M -64.43M
Sales Maturities Of Investments
82M 113.44M 140.33M 136.88M 189.97M 161.65M 138.27M 320.12M 147.26M 164.46M 220.38M 124.91M 108.45M 122.06M 199.22M 251.29M 111.73M 73M
Other Investing Acitivies
n/a -5M n/a n/a n/a n/a n/a n/a n/a -68.83M -179K 58.1M -56.26M 45.69M 68.59M -319.79M -459.24M 8.57M
Investing Cash Flow
25.28M 45.23M 58.24M 23.07M 76.84M -34.14M -66.58M 242.32M -98.59M -72.55M 80.4M 53.91M -60.28M 42.05M 65.75M -291.65M -460.81M 8.17M
Debt Repayment
n/a n/a 490K n/a -152K -338K -445K -486K -465K -446K -428K -410K -393K -377K n/a n/a -88K 895.62M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -50.69M n/a n/a n/a -82.09M -4.86M -4.25M 7.24M 1.25M 3.54M 848K 5.59M 1.32M 299.66M 2.97M -52.25M
Financial Cash Flow
n/a 1.96M -50.2M 812K -152K 6.55M -81.6M -781K -4.71M 195.99M 819K 3.13M 455K 5.21M 1.32M 299.66M 2.88M 865.72M
Net Cash Flow
-4.09M 3.14M -22.61M -21.2M 22.92M -103.27M -205.74M 176.36M -141.82M 25.52M 20.66M -6.01M -114.91M -37.24M 35.37M -32.65M -469.3M 846.45M
Free Cash Flow
-24.93M -50.45M -32.27M -44.68M -55.74M -79.56M -59.63M -66.01M -44.01M -98.41M -65.65M -67.24M -64.58M -82.67M -34.55M -41.77M -17.28M -23.5M